<DOC>
	<DOCNO>NCT02668146</DOCNO>
	<brief_summary>Obtain information whether medication Perampanel reduce tremor people essential tremor well-tolerated .</brief_summary>
	<brief_title>An Efficacy/Safety Study Perampanel Reducing Essential Tremor</brief_title>
	<detailed_description>Please see description `` Primary Secondary Outcomes '' .</detailed_description>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<criteria>1 . Subject review , sign date write informed consent form use protect health information [ Health Insurance Portability Accountability Act ( HIPAA ) Authorization ] , include videotape consent . 2 . Subject 18 older . 3 . Subject diagnosis definite probable essential tremor ( ET ) define Tremor Investigational Group , involvement hand arm least 2 year duration , without present cause enhance physiologic tremor , recent exposure tremorogenic drug drug withdrawal state , direct indirect trauma nervous system within 3 month precede onset tremor , historic clinical evidence psychogenic tremor origin . 4 . Tremor severity score least 2 least one upper extremity FahnTolosaMarin Tremor Rating Scale , least 1.5 TETRAS scale . 5 . Subject take dose one three antitremor medication least 4 week prior screen , inadequate response that/those medication ( ) , , bar unforeseen circumstance , continue duration study dose ( ) antitremor medication ( ) , OR Has fail least one course antitremor medication tolerate available antitremor medication ( ) , OR Is naive antitremor treatment refuse take available antitremor medication . 6 . If woman childbearing potential : A . Must unable become pregnant use adequate birth control ; B . Must define status post hysterectomy tubal ligation , 2 year postmenopausal , OR C. Otherwise document incapable pregnancy , practice one follow method contraception least two month prior screen : 1 ) hormonal contraceptive , 2 ) spermicide barrier method , 3 ) intrauterine device , 4 ) partner sterility , 5 ) abstinence , negative pregnancy test screening . 7 . Subject accessible telephone . 8 . Subject comply study visit , study drug compliance , study procedure . 9 . Subject stable dos medication least 4 week prior first baseline visit , , bar unforeseen circumstance , duration study 1 . Subject 's tremor adequately control current treatment . 2 . Subject pregnant , plan become pregnant study within 2 month complete study presently lactate breastfeed . 3 . Subject medical condition may cause explain subject 's tremor , limited , Parkinson 's disease , hyperthyroidism , pheochromocytoma , head trauma cerebrovascular disease within 3 month prior onset essential tremor ; multiple sclerosis , polyneuropathy family history Fragile X syndrome . 4 . Subject take medication ( ) might produce tremor interfere evaluation tremor , limited : CNSstimulants , stimulant decongestant , betaagonist bronchodilator , lithium , amiodarone , metoclopramide , theophylline , valproate , Irregular use ( `` need '' `` prn '' ) benzodiazepine , sleep medication anxiolytic ; ( However , regular use benzodiazepine , sleep medication anxiolytic improve sleep performance allow long tremor persist background regular medication use ) 5 . Subject surgical intervention tremor past ( e.g. , ablative thalamotomy gamma knife thalamotomy ) , botulinum toxin injection 6 month prior screen 6 . Subject use experimental drug within 4 week prior screen ( within 5 halflives , whichever long ) reason , OR use device treatment essential tremor 4 week prior screen , OR ever use deep brain stimulation reason 7 . Subject abstain use follow drug state period time prior clinic visit : caffeine ( 8 hour ) alcohol ( 12 hour ) . 8 . Subject abstain use alcohol prior drive vehicle operate heavy machinery . 9 . Subject history last 2 year alcohol substance abuse ( DSM 305 ) ; history consume 2 glass wine ( equivalent ) per day last 28 day prior screen . 10 . Subject history significant psychiatric disorder ( e.g. , mania , bipolar depressive disorder , schizophrenia , schizoaffective disorder , major psychiatric disorder ) , significant coagulation , immunologic , gastrointestinal , respiratory , cardiovascular ( e.g. , uncontrolled hypertension , myocardial infarction last 18 month , significant bundle branch block , congestive heart disease ) , endocrine ( e.g. , uncontrolled diabetes , hyperthyroidism ) disorder , current chronic infection , significant Screening laboratory ECG abnormality , acute chronic illness abnormality opinion Investigator preclude study participation . Subject Right Bundle Branch Block , pacemaker , control asthma control hypertension and/or control diabetes ( hemoglobin A1c &lt; 8 % ) acceptable , subject thyroid disease , provide euthyroid treatment . Subject single recurrent episode major depressive disorder ( DSM IV 296.20 .25 296.30.35 ) successfully manage stable dose ( 60 day ) antidepressant may consider entry . 11 . Subject liver disease mild . This defined transaminase level AST ALT great 50 % normal . 12 . Subject severe renal disease , define creatinine clearance le 39 ml/min . 13 . Subject suicide attempt , suicidal ideation intent , history aggression , include restrict violence threat violence , within past 2 year . 14 . Subject recent history hematologic/oncologic disorder ( within 2 year ) , successfully resolve cutaneous basal cell squamous cell carcinoma . Stability treatment prostate cancer also acceptable . 15 . Subject clinically significant impaired balance consider increased risk fall . 16 . Subject take phenytoin , carbamazepine , oxycarbazine , rifampin , St John 's wart , ketonazole consume grapefruit juice . 17 . Subject history take perampanel past .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>essential tremor</keyword>
	<keyword>Perampanel</keyword>
	<keyword>clinical trial</keyword>
</DOC>